Particulars | Q1FY25 | Q1FY24 | YoY % | Q4FY24 | QoQ % |
---|---|---|---|---|---|
Revenue from operations | 1288.00 | 1227.00 | 5.00% | 1230.00 | 5.00% |
EBITDA | 196.00 | 230.00 | -15.00% | 203.00 | -3.00% |
EBITDA Margin | 15.25% | 18.77% | (352) bps | 16.50% | (125) bps |
EBIT | 172.00 | 188.00 | -8.86% | 179.00 | -4.02% |
Profit after tax | 158.00 | 157.00 | 0.83% | 173.00 | -8.51% |
Source: Company Filings; stockaxis Research
Q1FY25 Result Highlights
Zensar Technologies reported steady growth across all the key segments. In Q1FY25,
the company reported revenue of $154.4M, sequential QoQ growth of 4.2% in reported
currency and 4.3% in constant currency. EBITDA declined 3.9% QoQ/16.0% YoY to INR1,962m
and EBITDA margin came in at 15.2%. Deal TCV came in at USD154m (-15% QoQ/flat YoY).
EBIT declined 4% QoQ/ 9% YoY to INR1,714m and EBIT margin was down 130bp at 13.3%.
Margins were impacted due to higher SG&A )110 bp QoQ), one-off due to bad debt
provisions) and higher cost of delivery. PAT declined 8.5% QoQ to Rs.158 cr.
For the second consecutive quarters, they have witnessed growth across all the verticals. Banking and Financial Services reported a sequential QoQ revenue growth of 6.8% in both reported and constant currency.
Manufacturing and Consumer Services reported a sequential QoQ revenue growth of 2.4% in reported currency and 2.7% in constant currency.
Telecommunication, Media, and Technology reported a sequential QoQ revenue growth of 1.2% in both reported and constant currency.
Healthcare and Life Sciences reported a sequential QoQ revenue growth of 6.9% in both reported and constant currency.
The US region reported a sequential QoQ revenue growth of 6.5% in reported currency and 6.6% in constant currency.
On July 17, 2024, Zensar has entered into definitive agreement for acquisition of 100% stake in Bridge View Life Sciences, a Pennsylvania-based technology and consulting solutions company in the Life Sciences industry. This move reinforces our focus on the Healthcare and Life Sciences vertical.
Significant Wins in Q1FY25
Providing migration of the data and configuration to the latest cloud-based instance for customers specialized in water analytics, and packaging services worldwide.
Partnered with a leading US based manufacturer and distributor of analytical instruments to implement a centralized and standardized Service Desk.
Multi-year Partner in Infrastructure Support, End User Computing, and Dispatch for a Global Mobility Solution Provider.
Helping Global Insurance clients with core data engineering activities and cost reduction by building semantic data models and working on Advanced Analytics
End to End application modernization for one of the largest banking vendors in South Africa.
Operational Highlights
Management Guidance
Future Outlook
Strategic Initiatives
Market Position and Strategy:
Key Highlights
Geographic Expansion:
New Regions: The company is exploring opportunities in new geographic
regions to diversify its revenue streams. This strategy aims to reduce dependency
on existing markets and drive growth through regional diversification.
Zensar Technologies’s strong deal pipeline and successful execution of strategic initiatives are likely to sustain this growth trajectory. Operational efficiencies and cost optimization initiatives are anticipated to expand margins. The company is focused on improving processes, increasing automation, and completing digital transformation projects to enhance customer experience and operational efficiency. Zensar Technologies plans to make strategic investments to drive long-term growth, emphasizing innovation and R&D. This includes continued investment in emerging technologies to maintain a competitive edge and exploring new geographic regions to diversify revenue streams.
Zensar has demonstrated growth across all verticals for the second consecutive quarter. Key segments such as Banking and Financial Services, Manufacturing and Consumer Services, Telecommunication Media and Technology, and Healthcare and Life Sciences have all shown positive revenue growth. Zensar’s focus on digital transformation and expanding its customer base, along with strategic partnerships and acquisitions, enhances its market position. We expect Zensar Tech’s revenue growth to improve in the long term, which will be led by healthy deal wins, restructure of the organization, incentivisation of sales, and cross selling, and diversified presence across various service lines and verticals. At a CMP of Rs.762, the stock is trading at 23x FY26E. We maintain a HOLD rating on the stock.
Particulars | Q1FY25 | Q1FY24 | YoY % | Q4FY24 | QoQ % |
---|---|---|---|---|---|
Revenue from operations | 1288.00 | 1227.00 | 5.00% | 1230.00 | 5.00% |
Total Revenue | 1288.00 | 1227.00 | 5.00% | 1230.00 | 5.00% |
Employee Cost | 815.70 | 766.00 | 7.00% | 780.00 | 5.00% |
Other exp | 276.00 | 231.00 | 19.00% | 247.00 | 12.00% |
EBITDA | 196.00 | 230.00 | -15.00% | 203.00 | -3.00% |
EBITDA Margin | 15.25% | 18.77% | (352) bps | 16.50% | (125) bps |
Depreciation and Amortisation | 24.70 | 42.00 | -41.19% | 24.00 | 2.92% |
EBIT | 172.00 | 188.00 | -8.86% | 179.00 | -4.02% |
Finance Cost | 4.20 | 6.00 | -30.00% | 2.80 | 50.00% |
Other Income | 42.40 | 28.40 | 49.30% | 52.00 | -18.46% |
Profit before tax | 210.00 | 211.00 | -0.43% | 228.00 | -7.98% |
Tax | 52.00 | 54.00 | -4.07% | 55.30 | -6.33% |
Profit after tax | 158.00 | 157.00 | 0.83% | 173.00 | -8.51% |
EPS | 6.96 | 6.90 | 0.87% | 7.65 | -9.02% |